These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
408 related items for PubMed ID: 9241082
1. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Logsdon MD, Ha CS, Kavadi VS, Cabanillas F, Hess MA, Cox JD. Cancer; 1997 Aug 01; 80(3):477-88. PubMed ID: 9241082 [Abstract] [Full Text] [Related]
2. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Li YX, Coucke PA, Li JY, Gu DZ, Liu XF, Zhou LQ, Mirimanoff RO, Yu ZH, Huang YR. Cancer; 1998 Aug 01; 83(3):449-56. PubMed ID: 9690537 [Abstract] [Full Text] [Related]
3. Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease. Proulx GM, Caudra-Garcia I, Ferry J, Harris N, Greco WR, Kaya U, Chan A, Wang CC. Am J Clin Oncol; 2003 Feb 01; 26(1):6-11. PubMed ID: 12576916 [Abstract] [Full Text] [Related]
4. Primary lymphomas of the nasal cavity and paranasal sinuses. Robbins KT, Fuller LM, Vlasak M, Osborne B, Jing BS, Velasquez WS, Sullivan JA. Cancer; 1985 Aug 15; 56(4):814-9. PubMed ID: 4016673 [Abstract] [Full Text] [Related]
5. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH. Ai Zheng; 2006 Apr 15; 25(4):465-70. PubMed ID: 16613682 [Abstract] [Full Text] [Related]
6. A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and paranasal sinuses. Robbins KT, Kong JS, Fuller LM, Goepfert H. J Otolaryngol; 1985 Feb 15; 14(1):7-13. PubMed ID: 4068097 [Abstract] [Full Text] [Related]
7. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J. Oral Oncol; 2008 Jan 15; 44(1):23-30. PubMed ID: 17306611 [Abstract] [Full Text] [Related]
8. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity. A report of 18 cases with stage IE disease. Tran LM, Mark R, Fu YS, Calcaterra T, Juillard G. Am J Clin Oncol; 1992 Jun 15; 15(3):222-5. PubMed ID: 1590274 [Abstract] [Full Text] [Related]
9. Stage III follicular lymphoma: long-term follow-up and patterns of failure. Ha CS, Kong JS, McLaughlin P, Tucker SL, Fayad LE, Hess MA, Wilder RB, Cabanillas F, Cox JD. Int J Radiat Oncol Biol Phys; 2003 Nov 01; 57(3):748-54. PubMed ID: 14529780 [Abstract] [Full Text] [Related]
10. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):182-90. PubMed ID: 12182990 [Abstract] [Full Text] [Related]
11. Malignant tumors of the nasal cavity and paranasal sinuses. Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB. Head Neck; 2002 Sep 01; 24(9):821-9. PubMed ID: 12211046 [Abstract] [Full Text] [Related]
12. [Non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses: clinicopathologic study of ten cases]. Chubachi A, Miura AB, Nishimura S, Akihama T, Kuwayama A, Saitoh M, Watanuki T. Rinsho Ketsueki; 1991 Jun 01; 32(6):675-80. PubMed ID: 1890745 [Abstract] [Full Text] [Related]
13. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Cancer; 2001 Dec 15; 92(12):3012-29. PubMed ID: 11753979 [Abstract] [Full Text] [Related]
14. Non-Hodgkin's malignant lymphoma of the sinonasal tract--treatment outcome for 53 patients according to REAL classification. Hatta C, Ogasawara H, Okita J, Kubota A, Ishida M, Sakagami M. Auris Nasus Larynx; 2001 Jan 15; 28(1):55-60. PubMed ID: 11137364 [Abstract] [Full Text] [Related]
15. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF. Zhonghua Zhong Liu Za Zhi; 2006 Jan 15; 28(1):58-61. PubMed ID: 16737624 [Abstract] [Full Text] [Related]
16. [Management and prognosis of patients with squamous cell carcinomas of the nasal cavity and the paranasal sinuses]. Pickhard A, Durst F, Staudenmaier R, Reiter R. Laryngorhinootologie; 2012 Oct 15; 91(10):627-32. PubMed ID: 22930278 [Abstract] [Full Text] [Related]
17. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Niu SQ, Yang Y, Li YY, Wen G, Wang L, Li ZM, Wang HY, Zhang LL, Xia YF, Zhang YJ. Chin J Cancer; 2016 Apr 04; 35():34. PubMed ID: 27044275 [Abstract] [Full Text] [Related]
18. Treatment outcome of nasal and paranasal sinus carcinoma. Hicsonmez A, Andrieu MN, Karaca M, Kurtman C. J Otolaryngol; 2005 Dec 04; 34(6):379-83. PubMed ID: 16343397 [Abstract] [Full Text] [Related]
19. Treatment of non-Hodgkin lymphomas in the nasal cavities and paranasal sinuses. A failure analysis. Kondo M, Mikata A, Inuyama Y, Uematsu M, Shigematsu N, Nishiguchi I, Hashimoto S. Acta Radiol Oncol; 1986 Dec 04; 25(2):91-7. PubMed ID: 3012963 [Abstract] [Full Text] [Related]
20. Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8). Milano AF. J Insur Med; 2024 Jul 01; 51(2):77-91. PubMed ID: 39266003 [Abstract] [Full Text] [Related] Page: [Next] [New Search]